Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Cerilliant
Colorcon
Dow
McKesson
Novartis
McKinsey
Accenture
Cipla

Generated: February 23, 2018

DrugPatentWatch Database Preview

Eptifibatide - Generic Drug Details

« Back to Dashboard

Pharmacology for eptifibatide

US Patents and Regulatory Information for eptifibatide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205581-001 Dec 8, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 204589-001 Apr 18, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 206127-002 Dec 8, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205557-001 Nov 6, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 091555-001 Jun 5, 2015 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 204589-002 Apr 18, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205581-002 Dec 8, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205557-002 Nov 6, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for eptifibatide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-002 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 ➤ Sign Up ➤ Sign Up
Schering INTEGRILIN eptifibatide INJECTABLE;INJECTION 020718-001 May 18, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Colorcon
Johnson and Johnson
Deloitte
Boehringer Ingelheim
US Department of Justice
Baxter
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot